openPR Logo
Press release

Synovial Sarcoma Market Forecast Research Reports Offers Key Insights

10-12-2017 03:38 PM CET | Health & Medicine

Press release from: Transparency Market Research

/ PR Agency: Transparency Market Research
Synovial Sarcoma Market Forecast Research Reports Offers Key

Synovial sarcoma is a predominantly juxta-articular, malignant, and soft-tissue tumour, which represents approximately 10% of all soft-tissue sarcomas. It was first reported in 1893, and due to its resembling characteristic with synovium, it was named as synovial sarcoma. As per the studies it has been observed that, synovial sarcomas are slow growing tumours and usually occur predominantly around knees, followed by the ankle, shoulder and elbow. Rise in incidence rate of all types of the cancer has been observed since last few decades. More than 60 percent of the world’s new cancer cases occur in Africa, Asia, and Central and South America & 70 percent of the world’s cancer deaths also occur in these regions. Moreover, cancer is the second-leading cause of death globally after cardiovascular disease, and the proportion of deaths around the world due to cancer has increased from 12% in 1990 to 15% in 2013 and according to the World Health Organization (WHO), cancer accounts for 8.3 million deaths each year, with 70% new cancer cases expected to be reported over the next 20 years. This is likely to provide significant opportunities for players in the synovial sarcoma market. According to the study represented by Sarcoma Foundation of America, Synovial sarcoma is the fourth most commonly occurring sarcoma, accounting for 8-10% of all sarcomas also, it has been observed that synovial sarcoma affects most commonly to the adolescent and young adults of age between 15 and 40.

Get Sample Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=28271

Strong focus on research and development to enhance the treatment options available such as targeted therapies and biological therapies. Treatment methods which include targeted therapies will increase the survival rates of patients as these therapies have low toxicity associated with their use. Currently, there is no targeted therapy yet. Moreover, strong and promising clinical pipeline is anticipated to fuel the synovial sarcoma market in near future. There are 83 pipeline therapeutics for the treatment of synovial sarcoma of which 8 drugs are under clinical phase III (clinicaltrials.gov). Also, innovative technologies like ZVex and GLAAS technology, RESOLYSIN technology, and tumour specific cytotoxic T-cell treatment are showing promising results. Thus, significant pipeline of the drugs, growing awareness among people and the increasing funding for research are major factors driving the growth of the market. However, the side effects associated with cancer treatment, high cost of treatment, stringent government regulations, and the high failure rate in the clinical trials, might hamper the growth of the market in the future.

The global synovial sarcoma market can be segmented on the basis of treatment type, end user and geography. On the basis of treatment type, the market can be segmented into chemotherapy, immunotherapy, radiation therapy, and surgery. On the basis of end-user the market can be segmented into hospitals, cancer research centers, ambulatory surgical centers, and others. Chemotherapy and immunotherapy are anticipated to dominate the synovial sarcoma market in the forecast period. Multi-specialty hospitals are anticipated to remain dominant during the forecast period.

Based on geography, the synovial sarcoma market can be segmented into five major regions: North America, Europe, Asia-Pacific, Latin America, and Middle East-Africa (MEA). At present, North America holds a leading position in the market followed by Europe. The major factors which have driven the market growth include development of innovative treatment, current FDA approval and rising adoption of innovative approach by patient and doctors. Moreover development of novel treatment and therapy for synovial sarcoma due to funding from Sarcoma Foundation of America and Synovial Sarcoma Research Foundation is also the major contributing factor for the growth of North America synovial sarcoma market. The population in developed countries is projected to have more number of patients due to the rise of obese patients and elderly population. This will drive more cancer prevalence and growth in revenue for the treatment methods.

View TOC for this Market Report @ http://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=28271

Various key players contributing to the global synovial sarcoma market comprises Pfizer Inc., F. Hoffmann-La Roche Ltd, Bayer AG, Epizyme, Inc., Cue Biopharma, TAKARA BIO INC., and Adaptimmune.

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Contact Us

Transparency Market Research
State Tower,
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Synovial Sarcoma Market Forecast Research Reports Offers Key Insights here

News-ID: 770920 • Views:

More Releases from Transparency Market Research

Global Autonomous Train Technology Market Forecast 2023-2031 - Market Size, Drivers, Trends, And Competitors
Global Autonomous Train Technology Market Forecast 2023-2031 - Market Size, Driv …
The autonomous train technology market is poised for substantial growth, reflecting a paradigm shift in the global transportation landscape. Valued at US$ 1.9 billion in 2022, the market is anticipated to witness a robust CAGR of 6.4%, reaching US$ 3.4 billion by 2031. This surge is attributed to key factors such as increased investments in railway infrastructure and the growing demand for reliable, sustainable, and energy-efficient transport systems. 𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐟𝐨𝐫 𝐚
Automotive Braking Component Market Size, Share And Growth Analysis For 2023-2031
Automotive Braking Component Market Size, Share And Growth Analysis For 2023-203 …
The global automotive braking component industry, valued at US$ 47.9 billion in 2022, is poised for significant growth, with an estimated Compound Annual Growth Rate (CAGR) of 4.0% from 2023 to 2031. Projections suggest that the market will reach US$ 68.3 billion by the end of 2031. This robust expansion is attributed to several key factors, including the surge in automotive production and vehicle ownership, advancements in safety technologies, and
Internet of Things (IoT) in Healthcare Market 2022: Industry Analysis, Size, Sha …
The Integration of Internet of Things (Iot) has emerged as a transformative force, catalyzing unprecedented advancements in patient care, operational efficiency, and overall healthcare outcomes. According to the latest market report, the IoT in Healthcare market was valued at a staggering US$ 91.71 billion in 2021 and is projected to exhibit a remarkable CAGR of 21.8% from 2022 to 2031, ultimately reaching an estimated value of US$ 648.94 billion by
Property Management Software Market Analysis, Size, Share, Growth, Trends, and F …
The Property Management Software Market is emerging as a key player in reshaping the way real estate is managed and optimized. According to recent press releases, the global property management software market was valued at an impressive US$ 14.89 billion in 2021, and projections indicate a robust compound annual growth rate (CAGR) of 8.21% from 2022 to 2031. This momentum is expected to catapult the market to a staggering US$

All 5 Releases


More Releases for America

Waterproof Labels Market Outlook, Supportive Judgments | SATO America, LANGGUTH …
Report Ocean recently published a new report on the Global Waterproof Labels Market. The study has an in-depth analysis of the forecast period from 2021-2025. The report reveals a comprehensive picture of the Waterproof Labels Market situation, taking into consideration all major trends, market dynamics, and competitive factors. Additionally, the report contains key statistics concerning the Waterproof Labels Market situation of the leading key players, key market trends, and potential
Textiles Market Analysis Report, Regional Outlook - Europe, North America, South …
Adroit Market Research has announced the addition of the “Global Textiles Market Size Status and Forecast 2025”, The report classifies the global Textiles in a precise manner to offer detailed insights about the aspects responsible for augmenting as well as restraining market growth. This report studies the global Textiles Speaker market, analyzes and researches the Textiles Speaker development status and forecast in Europe, North America, Central America, South America, Asia Pacific
Blow Molding Machinery Market Analysis Report, Regional Outlook - Europe, North …
Adroit Market Research has announced the addition of the “Global Blow Molding Machinery Market Size Status and Forecast 2025”, The report classifies the global Blow Molding Machinery in a precise manner to offer detailed insights about the aspects responsible for augmenting as well as restraining market growth. This report studies the global Blow Molding Machinery Speaker market, analyzes and researches the Blow Molding Machinery Speaker development status and forecast in Europe,
Global Gaucher Disease Market 2018 Covering North America, South America, Europe
Gaucher Disease Market Summary The Global Gaucher Disease Market is defined by the presence of some of the leading competitors operating in the market, including the well-established players and new entrants, and the suppliers, vendors, and distributors. The key players are continuously focusing on expanding their geographic reach and broadening their customer base, in order to expand their product portfolio and come up with new advancements. Gaucher Disease market size to maintain the average annual growth
Epigenetics Market by End Users, and by Geography North America, Latin America, …
Increasing research to study the epigenetics of the genome (study called epigenomics) is expected to boost growth of the epigenetics market over the forecast period. Genome-wide epigenetic studies play an important role in the diagnostics of human diseases. Moreover, implementation of epigenetics for oncology research is estimated to propel the growth of epigenetics market. For instance, Constellation Pharmaceuticals, in April 2018, invested US$ 100 million for development of cancer epigenetics
Spas and Beauty Salons Market - South America, Central America and North America …
Consumers’ changing perception towards personal care coupled with continuous strive to improve general well-being are generating a positive impact on the spas and beauty salons industry. Growing consumer need to improve personal appearance and well-being has increased the demand for wellness solutions. Spa centers and beauty salons, in order to meet the increasing demand for unique spa and beauty services, are constantly striving to improve their services by focusing on